Leon 2015.
Methods |
Study design: randomised controlled trial Study grouping: parallel group Eyes/people: 1 eye per person (study eye); unclear how this study eye was selected. |
|
Participants |
Baseline characteristics Toric IOLs
LRI
Overall
Inclusion criteria: significant cataract (II–IV group LOCS III), regular corneal astigmatism (1.0–2.0 D), with‐the‐rule astigmatism, mean axial length 23–24 mm, regular and symmetric astigmatism shape at the corneal topographic map, regular and with‐the‐rule astigmatism of the posterior corneal surface, pharmacologic mydriasis > 6.00 mm diameter to allow intraoperative and postoperative visualisation of axis marks on the toric IOLs. Exclusion criteria: previous surgery in the eye under study, irregular astigmatisms of the anterior or the posterior corneal surfaces, against‐the‐rule astigmatism, ocular diseases (pupil or zonular abnormalities, corneal scaring, uveitis, glaucoma, neuro‐ophthalmic diseases, significant macular disease or other retinopathy). Pretreatment differences: none |
|
Interventions |
Intervention characteristics Toric IOLs
LRI
|
|
Outcomes | Uncorrected distance visual acuity, best‐corrected distance visual acuity, topographic and keratometric changes in cornea, refractive evaluation and residual astigmatism, lens misalignment, endothelial cell count Adverse effects: not reported Follow‐up: 1, 3 and 6 months |
|
Identification |
Sponsorship source: not reported Country: Italy Authors name: Pia Leon Email: pialeon@libero.it Conflict of interest: none Date study conducted: January 2013 to June 2013 Trial registration ID: not reported |
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "Patients were randomly assigned to one of the two treatments computer. A randomized number was assigned to each patient when the inclusion and exclusion criteria were satisfied." |
Allocation concealment (selection bias) | Low risk | Quote: "Patients were randomly assigned to one of the two treatments computer. A randomized number was assigned to each patient when the inclusion and exclusion criteria were satisfied." Judgement comment: as the random allocation done after inclusion, implication is that the allocation was concealed. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Judgement comment: not reported. We contacted study authors for clarification but received no response. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Judgement comment: not reported. We contacted study authors for clarification but received no response. |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Judgement comment: not reported. We contacted study authors for clarification but received no response. |
Selective reporting (reporting bias) | Unclear risk | Judgement comment: insufficient information to judge. We contacted study authors for clarification but received no response. |